Vanguard Information Technology ETF (VGT)
| Assets | $84.97B |
| Expense Ratio | 0.09% |
| PE Ratio | 33.98 |
| Shares Out | 141.01M |
| Dividend (ttm) | $3.19 |
| Dividend Yield | 0.54% |
| Ex-Dividend Date | Mar 25, 2025 |
| Payout Ratio | 18.19% |
| 1-Year Return | +10.21% |
| Volume | 538,281 |
| Open | 590.71 |
| Previous Close | 602.19 |
| Day's Range | 590.08 - 598.83 |
| 52-Week Low | 451.00 |
| 52-Week High | 648.76 |
| Beta | 1.24 |
| Holdings | 310 |
| Inception Date | Jan 26, 2004 |
About VGT
Fund Home PageThe Vanguard Information Technology ETF (VGT) is an exchange-traded fund that mostly invests in information technology equity. The fund tracks a market cap-weighted index of companies in the US information technology sector. VGT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
59.75% of assets| Name | Symbol | Weight |
|---|---|---|
| Apple Inc. | AAPL | 17.17% |
| Microsoft Corporation | MSFT | 14.34% |
| NVIDIA Corporation | NVDA | 14.22% |
| Broadcom Inc. | AVGO | 4.45% |
| Salesforce, Inc. | CRM | 1.75% |
| Palantir Technologies Inc. | PLTR | 1.73% |
| Oracle Corporation | ORCL | 1.60% |
| Cisco Systems, Inc. | CSCO | 1.59% |
| International Business Machines Corporation | IBM | 1.55% |
| ServiceNow, Inc. | NOW | 1.37% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 25, 2025 | $0.7294 | Mar 27, 2025 |
| Dec 18, 2024 | $0.7766 | Dec 20, 2024 |
| Sep 27, 2024 | $0.9171 | Oct 1, 2024 |
| Jun 28, 2024 | $0.7624 | Jul 2, 2024 |
| Mar 22, 2024 | $1.259 | Mar 27, 2024 |
| Dec 19, 2023 | $0.7946 | Dec 22, 2023 |
News
Vergent Bioscience Presents Phase 2B VISUALIZE Results Demonstrating Abenacianine for Injection (VGT-309) with Intraoperative Molecular Imaging Improved Tumor Visualization During Lung Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor targeted imaging agents, announced new data being presented at the 2025 American Society of Cl...
VGT Vs. QQQ: Which Is The Best Growth ETF?
VGT offers slightly lower fees and broader tech sector exposure, but is more top-heavy and excludes major tech names like Amazon, Google, and Meta. QQQ provides access to the full Magnificent 7, is le...
VGT: I Want More Diversification
VGT's extreme concentration in its top three holdings undermines the diversification benefit I expect from an ETF. Current tech sector valuations are historically high, leaving little room for further...
Vergent Bioscience to Present Data on Abenacianine for Injection (VGT-309) at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that an abstract on abenacianine for injection (VGT-309) wi...
Tips for investing in tech now
Big tech has dominated the markets, but with tariffs and market uncertainty, what should investors do with the sector now? Ivana Delevska, Spear Invest Founder and CIO, joins Wealth to give some tips ...
VGT: In A Rut, Mixed Analysis, Hold Tight
Vanguard Information Technology Index Fund (VGT) is down 12% in the last month but has gained 3.5% over the last year. VGT is heavily weighted in Apple, Nvidia, and Microsoft, which account for nearly...
VGT: Great Opportunity To Buy The Tech Giants
VGT has outperformed the SP500 with an average return of 15.52% since 2004, despite recent volatility and a 24.12% loss this year. The ETF is heavily concentrated in tech giants like AAPL, NVDA, and M...
VGT: Vanguard's IT ETF - Buy The Sell-Off (Fortune Favors The Bold)
VGT ETF is down 11.8% YTD but boasts a strong 19.8% average annual return over the past decade, outperforming the S&P500 by ~7% annually. VGT is well-diversified across critical tech sub-sectors like ...
VGT: Has Become Expensive, Yet (Almost) Everyone Still Wants It
VGT is a leading tech ETF with a competitive Sharpe ratio, even compared to the Nasdaq and other Information Technology ETFs. VGT, like the Information Technology sector, has a negative current and fo...
Avoid the QQQ ETF, buy this Nasdaq 100 ETF alternative instead
The Invesco QQQ ETF has become one of the best-performing funds in the United States in the past few decades by tracking the Nasdaq 100 index. It has soared from about $40 during its inception and mov...
AI-themed ETFs plunge in wake of DeepSeek news
Prices of exchange-traded funds with outsize exposure to Nvidia plunged in the initial hours of trading on Monday in reaction to news that a Chinese startup has launched a powerful new artificial inte...
XSW Seems Better Than VGT In The Age Of DOGE
The SPDR S&P Software & Services ETF outperformed the Vanguard Information Technology Index Fund ETF due to anticipated growth in mid- and small-cap tech companies benefiting from deregulation. XSW's ...
VGT: The Only One To Hold
The technology sector, despite slowing earnings growth, remains attractive due to solid future earnings expectations and AI potential, with Vanguard Information Technology Index Fund ETF Shares (VGT) ...
Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that the U.S. Food & Drug Administration (FDA) has granted ...
VGT: Promising Long-Term Outlook With Short-Term Uncertainty
The tech sector thrived in 2024, with standout performances from Apple, Microsoft, and Nvidia, but potential volatility looms ahead. VGT is highly concentrated in its top three holdings, which poses r...
VGT: Why It Is A Strong Large Growth ETF
VGT has outperformed other large-cap ETFs like SPY and QQQ, making it a top recommendation for long-term holding due to its technology focus. Technology is the key growth driver, with ETFs like VGT ma...
VGT: Tech Stocks Look Tired
Mega-cap tech stocks have led the market, but VGT's heavy concentration in Apple, Microsoft, and NVIDIA poses risks if their charts turn bearish. VGT is not a diversified fund; nearly 60% of its holdi...
Vergent Bioscience Completes Enrollment in Phase 2 VISUALIZE Trial Evaluating Potential of Abenacianine for Injection (VGT-309) to Improve Tumor Visualization During Cancer Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company's Phase 2, ...
VGT: Less Attractive In An Era Of Mega Caps
VGT's concentrated portfolio, with Apple, Nvidia, and Microsoft at 45%, reduces diversification and limits upside potential to 6%. VGT tracks the MSCI US IMI/Information Technology 25/50 Index, which ...
VGT: A Fund For Technology's Next Big Run
VGT is a solid technology sector fund with a low expense ratio and superior risk-adjusted performance, despite slightly lagging its peers in total return. Technology's recent underperformance is due t...
VGT Is A Stronger Investment Option Than QQQ
VGT offers a competitive investment strategy with a lower expense ratio (10bps) and higher yield (0.65%) compared to QQQ, making it a strong buy for tech sector exposure. VGT's portfolio is highly con...
VGT: Relative Strength Suggests Caution Warranted
The Vanguard Information Technology ETF (VGT) is dominated by Apple, NVIDIA, and Microsoft, which together account for 44% of the ETF. The VGT ETF's recent underperformance relative to the S&P 500 sug...
VGT: Insane Concentration Risk
Tech is currently the most overcrowded sector, likely facing a meaningful correction soon, making it a risky allocation right now. Vanguard Information Technology ETF offers broad tech exposure but ha...